InfuSystem to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference September 12, 2024
04 Septiembre 2024 - 5:30AM
Business Wire
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or
the “Company”), a leading national health care service provider,
facilitating outpatient care for durable medical equipment
manufacturers and health care providers, announced today that
Richard DiIorio, Chief Executive Officer and Barry Steele, Chief
Financial Officer will participate in Lake Street Capital Markets’
8th Annual Best Ideas Growth (BIG8) Conference on Thursday,
September 12, 2024. The conference is being held at The Yale Club
in New York City.
Management will be available for one-on-one and group meetings
with investors throughout the day. To receive additional
information, request an invitation or to schedule a one-on-one
meeting, please email conference@lakestreetcm.com. Conversely, you may
also call or email Lytham Partners at 602-889-9700, or infu@lythampartners.com.
About the Lake Street "Big8" Conference
Lake Street Capital Markets is a research-powered investment
bank focused on growth companies. The Best Ideas Growth Conference
is Lake Street’s annual invitation-only event, featuring dynamic,
small-cap companies interacting with top institutional investors.
The format has been designed to give attendees direct access to
senior management via one-on-one & group meeting formats. Learn
more about the conference and Lake Street at https://www.lakestreetcapitalmarkets.com/big8conference.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading
national health care service provider, facilitating outpatient care
for durable medical equipment manufacturers and health care
providers. INFU services are provided under a two-platform model.
The first platform is Patient Services, providing the last-mile
solution for clinic-to-home healthcare where the continuing
treatment involves complex durable medical equipment and services.
The Patient Services segment is comprised of Oncology, Pain
Management and Wound Therapy businesses. The second platform,
Device Solutions, supports the Patient Services platform and
leverages strong service orientation to win incremental business
from its direct payer clients. The Device Solutions segment is
comprised of direct payer rentals, pump and consumable sales, and
biomedical services and repair. Headquartered in Rochester Hills,
Michigan, the Company delivers local, field-based customer support
and also operates Centers of Excellence in Michigan, Kansas,
California, Massachusetts, Texas and Ontario, Canada.
Forward-Looking Statements
Certain statements contained in this press release are
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, such as statements
relating to future actions, our share repurchase program and
capital allocation strategy, business plans, strategic
partnerships, growth initiatives, objectives and prospects, future
operating or financial performance, guidance and expected new
business relationships and the terms thereof (including estimated
potential revenue under new or existing contracts). The words
“believe,” “may,” “will,” “estimate,” “continue,” “anticipate,”
“intend,” “should,” “plan,” “goal,” “expect,” “strategy,” “future,”
“likely,” variations of such words, and other similar expressions,
as they relate to the Company, are intended to identify
forward-looking statements. Forward-looking statements are subject
to factors, risks and uncertainties that could cause actual results
to differ materially, including, but not limited to, our ability to
successfully execute on our growth initiatives and strategic
partnerships, our ability to enter into definitive agreements for
new business relationships on expected terms or at all, our ability
to generate estimated potential revenue amounts under new or
existing contracts, our dependence on estimates of collectible
revenue, potential litigation, changes in third-party reimbursement
processes, changes in law, global financial conditions and
recessionary risks, rising inflation and interest rates, supply
chain disruptions, systemic pressures in the banking sector,
including disruptions to credit markets, the Company’s ability to
remediate its previously disclosed material weakness in internal
control over financial reporting, contributions from acquired
businesses or new business lines, products or services and other
risk factors disclosed in the Company’s most recent annual report
on Form 10-K and, to the extent applicable, quarterly reports on
Form 10-Q. Our strategic partnerships are subject to similar
factors, risks and uncertainties. All forward-looking statements
made in this press release speak only as of the date hereof. We do
not undertake any obligation to update any forward-looking
statements to reflect future events or circumstances, except as
required by law.
Additional information about InfuSystem Holdings, Inc. is
available at www.infusystem.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240904318668/en/
Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC
602-889-9700
InfuSystems (AMEX:INFU)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024
InfuSystems (AMEX:INFU)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024